Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorSerratosa, Joan
dc.contributor.authorBove Badell, Jordi
dc.contributor.authorVila Bover, Miquel
dc.contributor.authorSaura, Josep
dc.contributor.authorSolà, Carme
dc.contributor.authorRabaneda-Lombarte, Neus
dc.date.accessioned2021-11-24T09:16:03Z
dc.date.available2021-11-24T09:16:03Z
dc.date.issued2021-04-06
dc.identifier.citationRabaneda-Lombarte N, Serratosa J, Bové J, Vila M, Saura J, Solà C. The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease. J Neuroinflammation. 2021 Apr 6;18:88.
dc.identifier.issn1742-2094
dc.identifier.urihttps://hdl.handle.net/11351/6592
dc.descriptionMicròglia; Neuroinflamació; Malaltia de Parkinson
dc.description.sponsorshipThis study was supported by grant PI15/00033 from the Instituto de Salud Carlos III (Spain) with joint financing by FEDER funds from the European Union. NRL was recipient of a predoctoral contract from the Spanish Ministerio de Educación. Cultura y Deporte FPU (FPU13/05491).
dc.language.isoeng
dc.publisherBMC
dc.relation.ispartofseriesJournal of Neuroinflammation;18
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectParkinson, Malaltia de - Tractament
dc.subjectMicròglia - Efecte dels medicaments
dc.subject.meshMicroglia
dc.subject.mesh/drug effects
dc.subject.meshParkinson Disease
dc.subject.mesh/drug therapy
dc.titleThe CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson’s disease
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1186/s12974-021-02132-z
dc.subject.decsmicroglía
dc.subject.decs/efectos de los fármacos
dc.subject.decsenfermedad de Parkinson
dc.subject.decs/farmacoterapia
dc.relation.publishversionhttps://doi.org/10.1186/s12974-021-02132-z
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Rabaneda-Lombarte N] Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain. Biochemistry and Molecular Biology Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain. [Serratosa J, Solà C] Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d’Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain. [Bové J] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERNED, Barcelona, Spain. [Vila M] Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. CIBERNED, Barcelona, Spain. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. [Saura J] Biochemistry and Molecular Biology Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain
dc.identifier.pmid33823877
dc.identifier.wos000637502400001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F00033
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/FPU13%2F05491
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple